ClinicalTrials.Veeva

Menu

An Open Platform of Serious Games for Cognitive Intervention

U

University of Alberta

Status

Suspended

Conditions

Aging
Alzheimer Disease
Mild Cognitive Impairment
Dementia

Treatments

Device: VibrantMinds

Study type

Interventional

Funder types

Other

Identifiers

NCT06366867
Pro00097579

Details and patient eligibility

About

Computer games are increasingly utilized as tools for studying cognitive skills, aging, individual differences, and development. They offer a unique advantage by presenting challenges that more closely mirror the complexities and demands of everyday tasks compared to traditional laboratory experiments, clinical tests, and standardized assessments. Our team took an innovative step in this direction by developing a suite of tablet-based games, titled VibrantMinds. These games, varying in type, are designed to measure diverse cognitive indicators, acting as proxies for assessments typically conducted using paper-and-pencil tests in clinical settings.

VibrantMinds games have been specifically crafted to be user-friendly and engaging for older adults, including those with dementia. Our studies have shown that these individuals not only find the games accessible but also exhibit measurable improvement in gameplay, suggesting potential benefits for cognitive skill training.

Building on this foundation, we are now poised to conduct an in-depth investigation into the actual effectiveness of serious computer games (SCGs) for cognitive enhancement and their application in real-world settings for older adults. This next phase of research will leverage the VibrantMinds platform to carry out studies aimed at validating software-defined indicators of cognitive function and measuring the impact of game-based interventions on cognitive abilities, health-related quality of life, and other significant real-life outcomes.

The anticipated results promise to expand our understanding of the potential for new technologies in cognitive assessment and intervention. Moreover, by employing machine learning analysis of the data collected through VibrantMinds, we aim to develop a taxonomy that correlates game complexity and player performance with conventional clinical instruments for assessing cognitive status and functioning.

Enrollment

122 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Older adults aged 65 years and older.
  • Cognitive impairment within a specific range as measured by the Mini-Mental State -Examination (MMSE scores between 7 and 25).
  • Ability to interact with the Serious Cognitive Games (SCGs) platform, indicating a necessary level of awareness.
  • Functional vision and hearing, with or without aids (glasses/hearing aids), to engage with the SCGs platform.
  • Functional upper extremity function to interact with the SCGs.

Exclusion criteria

  • Presence of influenza, COVID-19, or another virus that could affect performance or pose a risk to others.
  • Inability to communicate or comprehend instructions in English
  • Moderate to severe limitations in upper extremity control or movement, significant visual or hearing impairments, or attention deficits that could impact the ability to successfully engage with the SCGs. Participants or their care partners who feel these conditions would interfere with study participation are excluded.

Trial design

Primary purpose

Device Feasibility

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

122 participants in 2 patient groups

VibrantMinds + Standard Care
Experimental group
Description:
Older adults at long-term care facilities receive the VibrantMinds games in addition to routine standard care administered by the facility and staff.
Treatment:
Device: VibrantMinds
Standard Care
No Intervention group
Description:
Older adults at long-term care facilities receive routine standard care administered by the facility and staff.

Trial contacts and locations

1

Loading...

Central trial contact

Adriana M Rios Rincon, PhD, R.OT; Mathieu Figeys, PhD, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems